B3 · BRL
PFRM3
Profarma Distribuidora de Produtos Farmaceuticos SA
- Day's range
- R$7.22 – R$7.54
- Day's volume
- R$1.1m
- 52-week range
- R$6.11 – R$9.70
Follow PFRM3 on Fuolio
See how PFRM3 weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountPFRM3 in numbers
- Market cap
- R$917.5m
- P/E
- 5.94
- P/B
- 0.64
- Dividend yield (12m)
- 8.70%
- Net debt/EBITDA
- 1.85
The 12-month dividend yield of PFRM3 is 8.70%, above its 5-year average of 4.95%.
PFRM3 price history
PFRM3 risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | -2.82% | +130.16% | +72.31% |
| Volatility (annualised) | 24.44% | 46.78% | 41.44% |
| Largest drawdown | -25.93% | -25.93% | -43.23% |
| Positive months | 5/12 | 19/36 | 28/60 |
How much did investing in PFRM3 return?
R$1,000.00 invested on 01/09/2021 would be worth R$1,723.08 today.
- Value today in PFRM3
- R$1,723.08
- Return over the period
- +72.31%
- Return per year
- +11.50%
- In the Ibovespa
- R$1,657.66
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
PFRM3 fundamentals
Valuation
- P/E5.94
- P/B0.64
- EV/EBITDA3.22
- EV/EBIT4.73
- EV/Revenue0.17
- P/EBIT2.00
- P/S0.07
- P/OCF1.60
- P/FCF2.39
- Earnings yield21.16%
- PEG ratio0.19
- Earnings per shareR$1.25
- Book value per shareR$11.65
Debt
- Net debtR$1.2bn
- Net debt/EBITDA1.85
- Net debt/Equity0.74
- Debt/Equity1.03
- Current ratio1.37
- Quick ratio0.86
- Cash ratio0.12
Efficiency
- Gross margin15.14%
- EBITDA margin5.38%
- Operating margin3.67%
- Net margin1.29%
- Asset turnover1.56
Profitability
- ROE10.71%
- ROA2.02%
- ROIC13.52%
- Payout51.62%
Growth
- Revenue CAGR (5 years)16.22%
- Earnings CAGR (5 years)9.40%
- Revenue growth (year)12.77%
- Earnings growth (year)3.77%
- Revenue growth (quarter)13.20%
- Earnings growth (quarter)30.95%
What is PFRM3's fair price?
Two classic value formulas, with today's numbers. The current price is R$7.41.
- Graham's fair price
- R$18.09
- 144.14% above the price
√(22.50 × R$1.25 × R$11.65)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- R$5.77
- 22.14% below the price
R$0.35 (5-year average) ÷ 6%
Décio Bazin only bought shares yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years divided by 6%.
Graham ignores growth and debt; Bazin assumes past distributions will repeat. They are reference points for comparison, not a buy recommendation.
PFRM3 indicators by year
Multiples at each year's closing price; margins and returns from that year's accounts.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | 9.51 | 7.01 | 10.73 | 5.62 | 9.12 | 14.43 | 66.88 | -49.99 |
| P/B | 0.69 | 0.51 | 0.49 | 0.30 | 0.48 | 0.53 | 0.80 | 0.48 |
| EV/EBITDA | 3.93 | 2.93 | 3.27 | 2.45 | 4.22 | 4.42 | 6.53 | 10.08 |
| Dividend yield | 6.70% | 8.62% | 4.74% | 0.00% | 4.70% | 0.00% | 0.00% | 0.00% |
| Earnings per share | R$0.96 | R$0.93 | R$0.57 | R$0.65 | R$0.63 | R$0.42 | R$0.10 | -R$0.08 |
| Book value per share | R$13.21 | R$12.81 | R$12.43 | R$12.20 | R$11.92 | R$11.59 | R$8.11 | R$8.25 |
| ROE | 7.27% | 7.23% | 4.57% | 5.35% | 5.30% | 3.65% | 1.19% | -0.95% |
| ROIC | 13.13% | 13.35% | 11.73% | 12.20% | 7.08% | 7.25% | 2.34% | 1.24% |
| Gross margin | 15.29% | 15.00% | 14.92% | 14.66% | 14.15% | 13.93% | 15.37% | 15.94% |
| EBITDA margin | 4.80% | 4.62% | 4.73% | 4.88% | 4.00% | 4.06% | 3.96% | 2.08% |
| Net margin | 1.04% | 1.13% | 0.81% | 1.03% | 1.22% | 0.95% | 0.25% | -0.23% |
| Net debt/EBITDA | 1.87 | 1.22 | 1.43 | 1.26 | 1.44 | 1.03 | 2.32 | 4.59 |
PFRM3 financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | R$11.5bn | R$10.2bn | R$8.7bn | R$7.8bn | R$6.4bn | R$5.5bn |
| Cost of sales | -R$9.7bn | -R$8.6bn | -R$7.4bn | -R$6.7bn | -R$5.5bn | -R$4.7bn |
| Gross profit | R$1.8bn | R$1.5bn | R$1.3bn | R$1.1bn | R$907.6m | R$763.6m |
| EBITDA | R$550.1m | R$469.2m | R$409.7m | R$381.2m | R$256.6m | R$222.6m |
| EBIT | R$350m | R$299.7m | R$261.1m | R$242.9m | R$130.7m | R$120.6m |
| Net finance result | -R$232.5m | -R$171.8m | -R$179.5m | -R$164m | -R$82m | -R$87.5m |
| Profit before tax | R$117.5m | R$127.9m | R$81.6m | R$79m | R$48.7m | R$33.1m |
| Income tax | R$8.6m | -R$5m | -R$3.7m | R$6.1m | R$30.4m | R$28.6m |
| Net income | R$118.9m | R$114.6m | R$70.4m | R$80.9m | R$78.2m | R$52.3m |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
PFRM3 against its sector
The same indicators for the company's other shares and the sector's largest stocks.
| Stock | P/E | P/B | Dividend yield (12m) | ROE | Market cap |
|---|---|---|---|---|---|
| PFRM3Profarma Distrib Prod Farmaceuticos | 5.94 | 0.64 | 8.70% | 10.71% | R$917.5m |
| BEEF3MINERVA S.A. | 8.60 | 2.50 | 4.97% | 29.04% | R$3.9bn |
| RIAA3RIAA3 | 2.35 | 0.67 | 45.40% | 28.35% | R$3.6bn |
| WLMM4WLM PART. E COMÉRCIO DE MÁQUINAS E VEÍCULOS S.A. | 7.37 | 0.71 | 12.38% | 9.63% | R$590.4m |
| WLMM3WLM PART. E COMÉRCIO DE MÁQUINAS E VEÍCULOS S.A. | 7.74 | 0.75 | 10.71% | 9.63% | R$590.4m |
| DMVF3D1000 VAREJO FARMA PARTICIPAÇÕES S.A. | 14.08 | 0.33 | 0.00% | 2.35% | R$306.1m |
Does PFRM3 pay dividends?
Dividend yield per year
- 0.00%2017
- 0.00%2018
- 0.00%2019
- 0.00%2020
- 4.70%2021
- 0.00%2022
- 4.74%2023
- 8.62%2024
- 6.70%2025
- 4.29%2026
| Type | Last day to own | Payment | Per share |
|---|---|---|---|
| Dividend | 30/12/2025 | 15/01/2026 | R$0.32 |
| Dividend | 28/11/2025 | 23/12/2025 | R$0.16 |
| Dividend | 31/10/2025 | 25/11/2025 | R$0.16 |
| Interest on equity | 30/12/2024 | 15/01/2025 | R$0.29 |
| Interest on equity | 29/11/2024 | 12/12/2024 | R$0.14 |
| Interest on equity | 11/11/2024 | 26/11/2024 | R$0.14 |
| Interest on equity | 28/12/2023 | 10/01/2024 | R$0.27 |
| Interest on equity | 30/11/2023 | 12/12/2023 | R$0.12 |
| Interest on equity | 20/12/2022 | 13/01/2023 | R$0.17 |
| Interest on equity | 19/11/2021 | 01/12/2021 | R$0.27 |
| Dividend | 30/04/2014 | 14/05/2014 | R$0.13 |
| Dividend | 30/04/2014 | 13/05/2014 | R$0.14 |
See all 19 distributions
| Type | Last day to own | Payment | Per share |
|---|---|---|---|
| Dividend | 29/04/2013 | 10/05/2013 | R$0.20 |
| Dividend | 29/04/2011 | 12/05/2011 | R$0.13 |
| Dividend | 30/04/2010 | 12/05/2010 | R$0.26 |
| Dividend | 13/04/2009 | 27/04/2009 | R$0.11 |
| Dividend | 03/04/2008 | 14/04/2008 | R$0.08 |
| Interest on equity | 28/12/2007 | 14/04/2008 | R$0.14 |
| Dividend | 23/04/2012 | — | R$0.14 |
About Profarma Distrib Prod Farmaceuticos
- Sector
- Consumo Não Cíclico
- Segment
- Medicamentos e Outros Produtos
- Listing segment
- Novo Mercado
- Tag along
- 100.00%
- Free float
- 32.50%
- Shares issued
- 123.81m ordinary
- Average daily trading
- R$882.2k
- Listed since
- 26/10/2006
- CNPJ
- 45.453.214/0001-51
Grupo Profarma é uma empresa brasileira especializada em distribuição e varejo no segmento farmacêutico, com mais de 60 anos de atuação no mercado. A companhia opera uma plataforma integrada de distribuição e varejo, contando com 15 centros de distribuição estrategicamente posicionados e quatro bandeiras de farmácias (Rede d1000, Drogasmil, Farmalife e Tamoio). A Profarma Distribuição é referência nacional em logística farmacêutica, conectando indústrias a mais de 49 mil pontos de venda com eficiência e segurança, cobrindo 17 estados brasileiros. A empresa entrega medicamentos, produtos de higiene e beleza com excelência, operando com frota própria e terceirizada, além de plataforma digital que facilita gestão de pedidos e abastecimento do canal farmacêutico.
Investor website| Shareholder | Ordinary | Preferred | Total |
|---|---|---|---|
| BPL Brazil Holding Company | 38.18% | 0.00% | 38.18% |
| BMK Participações S.A.Controlling | 25.57% | 0.00% | 25.57% |
| LIS Capital Gestora Ltda | 9.13% | 0.00% | 9.13% |
| MANOEL BIRMARCKER | 1.18% | 0.00% | 1.18% |
| SAMMY BIRMARCKER | 1.11% | 0.00% | 1.11% |
| CACILDA DELEGAVE BIRMARCKER | 0.08% | 0.00% | 0.08% |
| DEBORAH UDERMAN | 0.06% | 0.00% | 0.06% |
| Outros | 23.73% | 0.00% | 23.73% |
| Ações Tesouraria | 0.97% | 0.00% | 0.97% |
Questions about PFRM3
How much is PFRM3 today?
PFRM3 is at R$7.41 (-0.40% on the day), last traded on 01/10/2026.
How much did PFRM3 pay in dividends in 2025?
PFRM3 paid R$0.61 per share in 2025, a dividend yield of 6.70%.
What are the P/E and P/B of PFRM3?
PFRM3 trades at a P/E of 5.94 and a P/B of 0.64.
How much did PFRM3 return in 12 months?
PFRM3 returned -2.82% in 12 months, with annualised volatility of 24.44% and a largest drawdown of -25.93%.
What sector is PFRM3 in?
Profarma Distrib Prod Farmaceuticos is in the Consumo Não Cíclico sector, Medicamentos e Outros Produtos segment.